Indian government has been found to be spending less as 0.04 percent of the GDP for its flagship Indira Gandhi National Social Assistance (IGNOAPS) programme for ensuring income security for the elderly.
Doctors Strike Against Suspension of Colleague in Kerala, South India
The medical fraternity demands the withdrawal of suspension of the doctor who was on duty at the General Hospital, Thiruvananthapuram last Tuesday.
The medical fraternity demands the withdrawal of suspension of the doctor who was on duty at the General Hospital, Thiruvananthapuram last Tuesday.
‘The most astonishing fact is that It will cost only about 1.6 percent of the present-day GDP to ensure 90 percent of the elderly population
’
"It will cost only about 1.6 percent of the present-day GDP to ensure 90 percent of the elderly population a pension of Rs 2,500 per person every month," Patnaik said. According to the National Social Assistance Programme (NSAP), a welfare programme administered by the Ministry of Rural Development, 80 million elderly people in India are entitled to a pension of Rs 200 per month.
This meager amount reaches only about 22.3 million people, Pension Parishad Coordinator, Nikhil Dey said.
Streamline IV Suspension System Eases Intra-Hospital Transportation of Critical Patients
Medovex’s Streamline IV Suspension System helps caregivers handle the growing amount of patient equipment that remains with patients as they move about a hospital.
Medovex’s Streamline IV Suspension System helps caregivers handle the growing amount of patient equipment that remains with patients as they move about a hospital.
Source-IANS
Bionic Eye Helps A Partially Sighted British Pensioner To See The World Again
An 80-year-old partially sighted British pensioner, Ray Flynn, has had most of his vision restored after a successful operation, thanks to a bionic eye.
An 80-year-old partially sighted British pensioner, Ray Flynn, has had most of his vision restored after a successful operation, thanks to a bionic eye.
European Medical Agency Confirms Suspension of Drugs Over Flawed Clinical Trials
GVK Biosciences, Hyderabad, India was held at stake when the European drug regulatory found flaws in conduct of some studies of generic medicines.
GVK Biosciences, Hyderabad, India was held at stake when the European drug regulatory found flaws in conduct of some studies of generic medicines.
